Related Experiment Videos
Propantheline bromide in massive upper gastrointestinal haemorrhage
Upsala Journal of Medical Sciences
|January 1, 1975
Summary
Propantheline bromide did not improve overall outcomes for upper gastro-intestinal bleeding patients. However, younger patients under 50 experienced a reduced need for blood transfusions.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Upper gastro-intestinal bleeding is a significant medical condition requiring effective treatment.
- Anticholinergic agents are sometimes considered for managing gastrointestinal issues.
Purpose of the Study:
- To evaluate the efficacy of propantheline bromide in patients with upper gastro-intestinal bleeding.
- To assess the impact of propantheline bromide on clinical outcomes and transfusion requirements.
Main Methods:
- A double-blind study was conducted involving 99 patients.
- Patients received either propantheline bromide or a placebo parenterally.
Main Results:
- No significant differences were observed in intensive care duration, total hospital stay, or surgical frequency between the groups.
- A notable finding was a significantly lower blood transfusion requirement in patients under 50 years of age who received propantheline bromide.
Conclusions:
- Parenteral propantheline bromide did not demonstrate overall clinical benefits for upper gastro-intestinal bleeding in this study.
- Propantheline bromide may offer a specific benefit in reducing transfusion needs for younger patients (<50 years) with upper gastro-intestinal bleeding.